The National Institutes of Health (NIH) unit of the National Institute of Allergy and Infectious Diseases (NIAID) has ...

Poseida Therapeutics' lead allogeneic chimeric antigen receptor T-cell candidate it is co-developing with Roche will advance to Phase Ib.

Europe has announced a €2 million project to research long COVID, following €100 million already invested since 2021. Is all ...

Northwestern Medicine scientists have discovered a new mechanism that controls a specialized group of T-cells, known as ...

Quell’s proprietary platform has been developed to generate engineered CAR-Treg cell therapies that can be directed to ...

For human tissues, prior experimental manipulations are impractical, and genomic alterations are employed. Somatic mutations mark subclones and their fates can be reconstructed with DNA sequencing ...

Neuroscientists have discovered how the CP-AMPA receptor in brain cells influences neuron selectivity in response to sensory stimuli.

AT&T Intellectual Property has been granted U.S. patent #12095813 for a system that detects homoglyph attacks, invented by ...